CEFTAZIDIME/AVIBACTAM: A NOVEL ANTIMICROBIAL FOR MULTIDRUG-RESISTANT PSEUDOMONAS IN CYSTIC FIBROSIS

Atkin S. D.; Foster M. L.; Abid S.; Bose M.; Keller A.; Jain R.

首页> 外文期刊>Pediatric Pulmonology >CEFTAZIDIME/AVIBACTAM: A NOVEL ANTIMICROBIAL FOR MULTIDRUG-RESISTANT PSEUDOMONAS IN CYSTIC FIBROSIS

【24h】

CEFTAZIDIME/AVIBACTAM: A NOVEL ANTIMICROBIAL FOR MULTIDRUG-RESISTANT PSEUDOMONAS IN CYSTIC FIBROSIS

机译：Ceftazidime / Avibactam：一种新型抗菌纤维化抗性假单胞菌的抗菌剂

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric Pulmonology》 |2016年第45期|共1页
作者
Atkin S. D.; Foster M. L.; Abid S.; Bose M.; Keller A.; Jain R.;
展开▼
作者单位

Univ Texas Southwestern Dallas TX USA;

Univ Texas Southwestern Dallas TX USA;

Univ Texas Southwestern Dallas TX USA;

Univ Texas Southwestern Dallas TX USA;

Univ Texas Southwestern Dallas TX USA;

Univ Texas Southwestern Dallas TX USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. CEFTAZIDIME/AVIBACTAM: A NOVEL ANTIMICROBIAL FOR MULTIDRUG-RESISTANT PSEUDOMONAS IN CYSTIC FIBROSIS [J] . Atkin S. D., Foster M. L., Abid S., Pediatric Pulmonology . 2016,第Suppla45期

机译：Ceftazidime / Avibactam：一种新型抗菌纤维化抗性假单胞菌的抗菌剂
2. Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa [J] . Adnan Alatoom, Hashim Elsayed, Karen Lawlor, International journal of infectious diseases : . 2017,第Supplementa1期

机译：头孢唑烷-他唑巴坦和头孢他啶-avibactam对大肠杆菌，肺炎克雷伯菌和铜绿假单胞菌等多重耐药菌株的抗菌活性比较
3. Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from US Medical Centers, 2013 to 2016 [J] . Sader Helio S., Castanheira Mariana, Shortridge Dee, Antimicrobial agents and chemotherapy. . 2017,第11期

机译：Ceftazidime-Avibactam的抗菌活性对来自美国医疗中心的多药肠杆菌和铜绿假单胞菌和假单胞菌铜绿假单胞菌的抗菌活性。2013年至2016年
4. MEMBRANE PROTEOME CHARACTERIZATION OF PHENOTYPICALLY DIVERSE PSEUDOMONAS AERUGINOSA CYSTIC FIBROSIS ISOLATES REVEALS ADAPTATION TO HOST LUNGS [C] . Karthik Shantharam Kamath, Dana Pascovici, Apurv Goel, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：表型多样性铜绿假单胞菌孢子素囊性纤维化分离物的膜蛋白质组特征揭示了对宿主肺的适应
5. Treating an N-glycosylation abnormality in airways with a cystic fibrosis transmembrane conductance regulator protein deficiency reduces Pseudomonas aeruginosa colonization; A hallmark symptom of cystic fibrosis [D] . Martino, Ashley Thomas 2007

机译：用囊性纤维化跨膜电导调节蛋白缺乏治疗气道N-糖基化异常可减少铜绿假单胞菌定植；囊性纤维化的典型症状
6. Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam [O] . Stan D Atkin, Shadaan Abid, Michael Foster, 2018

机译：囊性纤维化患者痰液中的多药耐药铜绿假单胞菌显示对头孢他啶-阿维巴坦的敏感性高
7. 2383. In Vitro Activity of Ceftolozane–Tazobactam in Comparison With Ceftazidime–Avibactam vs. Antimicrobial Non-Susceptible Pseudomonas aeruginosa Clinical Isolates, Including Multidrug-Resistant and Extensively Drug-Resistant Subsets: CANWARD, 2007–2017 [O] . Andrew Walkty, Heather J Adam, Melanie Baxter, 2018

机译：2383.与Ceftazidime-Avibactam与抗微生物非易感假单胞菌铜绿假单胞菌临床分离株相比，CEFTOLOZANE-TaZabactam的体外活性，包括多药和广泛的耐药子集：CANWARD，2007-2017

CEFTAZIDIME/AVIBACTAM: A NOVEL ANTIMICROBIAL FOR MULTIDRUG-RESISTANT PSEUDOMONAS IN CYSTIC FIBROSIS

著录项

相似文献

相关主题

期刊订阅